A Drug-Drug Interaction Study of Warfarin and PA21

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Drug Interaction Potentiation

Interventions

DRUG

PA21

The maximum dose of PA21 will be 15.0 g/day.

DRUG

Warfarin

The maximum dosage of Warfarin will be 10 mg/day

Trial Locations (1)

PRA International - Clinical Pharmacology Center, Lenexa